Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
Authors:
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 97 (5) , 584-592
Abstract
Chemotherapeutic drugs eliminate cancer cells by induction of apoptosis. Resistance to chemotherapy is partly due to a decreased apoptosis rate. Here we investigated resistance to anticancer drugs in 9 small cell lung cancer (SCLC) cell lines. Apoptosis was induced by cisplatin, doxorubicin and etoposide and was found to be independent of caspase‐8 expression. Since caspase‐8 is essential for signal transduction of death receptor‐mediated apoptosis, all known death receptor systems are thus not required for drug‐induced apoptosis in SCLC. Furthermore, we found that anticancer drugs could activate the mitochondrial pathway of apoptosis without involvement of upstream caspases. Finally, by culturing 3 sensitive cell lines in subtherapeutic concentrations of etoposide, resistant cells were generated that exhibit cross‐resistance to cisplatin and doxorubicin. Drug resistance was paralleled by strong upregulation of Bcl‐2, which diminished apoptosis by inhibiting the loss of the mitochondrial transmembrane potential and the release of cytochrome c. The role of bcl‐2 in these processes was supported by bcl‐2 transfection and antisense inhibition. These results indicate that Bcl‐2 contributes to drug resistance in SCLC, a finding that has profound therapeutic implications.Keywords
This publication has 58 references indexed in Scilit:
- Differences in Expression of Pro-Caspases in Small Cell and Non-small Cell Lung CarcinomaBiochemical and Biophysical Research Communications, 1999
- Bcl-2–Mediated Drug ResistanceJournal of Experimental Medicine, 1999
- Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition poreOncogene, 1999
- Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of ApoptosisScience, 1998
- The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell deathOncogene, 1997
- Resistance of cultured peripheral T cells towards activation‐induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death‐inducing signaling complexEuropean Journal of Immunology, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Apoptosis of Lung Cancer Cells Caused by Some Anti-cancer Agents (MMC, CPT-11, ADM) is Inhibited by BCL-2Biochemical and Biophysical Research Communications, 1993